COONRAD/MORREY TOTAL ELBOW, MODEL 8105 SERIES

{0}------------------------------------------------ Image /page/0/Picture/0 description: The image shows the logo for Zimmer. The logo consists of a large, stylized "Z" inside of a circle, followed by the word "zimmer" in a sans-serif font. The logo is black and white and appears to be a company logo. # KOS 3189 #### DEC 9 2005 Summary of Safety and Effectiveness | Submitter: | Zimmer, Inc.<br>P.O. Box 708<br>Warsaw, IN 46581-0708 | |--------------------------------------|---------------------------------------------------------------------------------------------------------------------| | Contact Person: | Laura D. Williams, RAC<br>Manager, Corporate Regulatory Affairs<br>Telephone: (574) 372-4523<br>Fax: (574) 372-4605 | | Date: | November 11, 2005 | | Trade Name: | Coonrad/Morrey Total Elbow | | Common Name: | Total Elbow Prosthesis | | Classification Name<br>and Reference | Elbow joint metal/polymer constrained elbow<br>prosthesis - 21 CFR § 888.3150 | | Predicate Device: | Coonrad/Morrey Total Elbow,<br>manufactured by Zimmer, Inc.,<br>K001989, cleared July 25, 2000 | Device Description: The Coonrad Morrey Total Elbow is a total elbow prosthesis designed for use with bone cement. It is available in regular, small and extra small sizes, in right and left configurations. #### Intended Use: Indications include: post-traumatic lesions or bone loss contributing to elbow instability; ankylosed joints, especially in cases of bilateral ankylosis from causes other than sepsis; advanced rheumatoid or degenerative arthritis with incapacitating pain; revision arthroplasty, and instability or loss of motion when the degree of joint damage precludes less radical procedures. The candidate for total elbow arthroplasty should exhibit joint destruction which significantly compromises the activities of daily living. Patient with single joint involvement (generally those with traumatic or degenerative arthritis) or significant lower extremity disability which require walking aids are less amenable to treatment than patients with advanced and predominantly upper extremity involvement. If possible, elbow replacement should be done after hip or knee surgery to avoid excessive stress to the prosthesis required by crutch walking during total hip or knee rchabilitation. {1}------------------------------------------------ KCS3189 (pg 2 of 2) Image /page/1/Picture/1 description: The image contains the logo for Zimmer. The logo consists of a large, stylized letter "Z" inside of a circle. To the right of the circle is the word "zimmer" in a smaller, sans-serif font. ## Comparison to Predicate Device: Ulnar Assemblies of modified stem length are being added to accommodate varying anatomy. All other dimensions will remain unchanged compared to the predicate devices. #### Performance Data (Nonclinical and/or Clinical): Results of nonclinical analysis indicate that the modified device is substantially equivalent to the predicate. {2}------------------------------------------------ Image /page/2/Picture/1 description: The image shows the logo for the U.S. Department of Health and Human Services. The logo features a stylized caduceus, which is a symbol often associated with medicine and healthcare. The words "DEPARTMENT OF HEALTH AND HUMAN SERVICES . USA" are arranged in a circular pattern around the caduceus. DEC 9 2005 Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850 Laura D. Williams, RAC Manager, Corporate Regulatory Affairs Zimmer. Inc. P.O. Box 708 Warsaw, Indiana 46581-0708 Re: K053189 Trade/Device Name: Coonrad/Morrey Total Elbow Regulation Number: 21 CFR 888.3150 Regulation Name: Elbow joint metal/polymer constrained cemented prosthesis Regulatory Class: II Product Code: JDC Dated: November 11, 2005 Received: November 15, 2005 Dear Ms. Williams: We have reviewed your Section 510(k) premarket notification of intent to market the device we nave reviewed your bectorn 310(t) presidentially equivalent (for the indications felerenced above and nave determined in the enclicate devices marketed in interstate for use stated in the cherosure) to regally manetteent date of the Medical Device American be of Drya commerce prior to May 20, 1976, the encordance with the provisions of the Federal Food, Drug. devices that have been reclassified in accordance with the provisions of the Fed devices that have been recuire approval of a premarket approval application (PMA). and Cosment Act (Act) that do not requent appen to the general controls provisions of the Act. The r ou may, therefore, market the act include requirements for annual registration, listing of general controls provisions of use tice, labeling, and prohibitions against misbranding and adulteration. If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it If your device is classified (see above) into existing major regulations affecting your device can may be subject to such additional controls. Existing major regulations on may be subject to such additional controller Entroller Controller. be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may be found in the Code of Peachartergarine your device in the Federal Register. Please be advised that FDA's issuance of a substantial equivalence determination does not mean Please be advised that I DA s issualled of a succession in other requirements of the Act that I'DA has made a decemination administered by other Federal agencies. You must or any Federal statutes and regulations annualing, but not limited to: registration and listing (21 comply with an the Ace 31equirements, and manufacturing practice requirements as set CTN in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic form in the quality systems (Sections 531-542 of the Act); 21 CFR 1000-1050. {3}------------------------------------------------ Page 2 - Laura D. Williams, RAC This letter will allow you to begin marketing your device as described in your Section 510(k) I mis lotter will and myour he FDA finding of substantial equivalence of your device to a legally promation notineation: "The PDF and elessification for your device and thus, permits your device to proceed to the market. If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please If you dosire of Compliance at (240) 276-0120. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). You may obtain other general information on your responsibilities under the Act from the Division of Small other Ectorers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its Internet address http://www.fda.gov/cdrh/industry/support/index.html. Sincerely yours, Mark N. Melkerson Acting Director Division of General, Restorative and Neurological Devices Office of Device Evaluation Center for Devices and Radiological Health Enclosure {4}------------------------------------------------ K053189 ### Indications for Use 510(k) Number (if known): Device Name: Coonrad/Morrey Total Elbow #### Indications for Use: Indications include: post-traumatic lesions or bone loss contributing to elbow instability; ankylosed joints, especially in cases of bilateral ankylosis from causes other than sepsis; advanced rheumatoid or degenerative arthritis with incapacitating pain; revision arthroplasty, and instability or loss of motion when the degree of joint damage precludes less radical procedures. The candidate for total elbow arthroplasty should exhibit joint destruction which significantly compromises the activities of daily living. Patient with single joint involvement (generally those with traumatic or degenerative arthritis) or significant lower extremity disability which require walking aids are less amenable to treatment than patients with advanced and predominantly upper extremity involvement. If possible, elbow replacement should be done after hip or knee surgery to avoid excessive stress to the prosthesis required by crutch walking during total hip or knee rehabilitation. Prescription Use _ X (Part 21 CFR 801 Subpart D) AND/OR Over-The-Counter Use __ (21 CFR 807 Subpart C) (Please do not write below this line - Continue on another page if needed) Concurrence of CDRH, Office of Device Evaluation (ODE) ZS (Division Sign-Off) Division of General, Restorative, and Neurological Devices Page 1 of 1 510(k) Number_ K053189